HASTICELL
Innovator:
Ms. Hasti Sadat Hosseini
Owner of the innovation:
Biological Dressing Made of Amniotic Membrane for the Treatment of Uterine Wall Wounds (Hasticell)
Acknowledgment: Congratulations on being one of the pioneer innovators who have obtained the IFIA Innovation Standard certificate (IIS).
Following your inquiry for an IIS certification, the jury board evaluated your application according to the criteria. And after the assessment and examinations, your innovation was granted with IFIA Innovation Standard Grade A.
IFIA hopes that by having this certification, you will take an essential step in the commercialization of your innovation. Also, by entering international markets, you can contribute to the realization of the global slogan: Generating wealth through innovative knowledge.
The Summary of Innovation:
This invention is about stem cell grafts to repair wounds, especially cervical wounds and the negative side effects of HPV on the cervix. This miraculous graft is effective in other fields of medicine and surgery. It is extracted from the fetal membrane of the placenta. Biological Dressing Made of Amniotic Membrane comprising:
- An epithelial cell layer;
- A thick basement membrane;
- An avascular stromal matrix;
after the separation of the amniotic membrane, the Amniodisc undergoes preparation, drying, and complete sterilization processes, this product can be produced and used in two forms: dry and wet discs. This invention is completely evidence-based and has positive laboratory and clinical results on a population of two hundred people.
And nine years of experience in studying and researching in articles and laboratories have been brought to bear in this invention.
This humanitarian and innovative invention will enter international treatment markets and has the potential to treat many people after contracting HPV and cervical, anal, and prostate cancer, and deserves to receive global standards
Advantageous Effects of Invention
Utilizing advanced technologies and higher-quality materials, which reduce issues related to powdering and adhesion of the dressing.
- Optimized storage methods that, by employing modern preservation techniques,
Minimize or eliminate the need for refrigeration, reducing storage-related challenges.
- Enhanced production processes and the use of appropriate disinfectants,
Allowing Amniodisc dressings to lower the risk of infection and improve treatment outcomes.
- Easier application to the target area.
- Offering various types of Amniodisc in different sizes and shapes, tailored for the cervix and different types of wounds.
Examples
The Amniodisc comes in sizes of 2×2 cm, 5×5 cm, or 10×10 cm and is applied to the cervix like a regular dressing. The Amniodisc adheres to the wound, gets absorbed, and promotes healing. After one month, the patient must visit the relevant physician, and if necessary, another layer of Amniodisc can be applied to the wound and dressed again.
Industrial Applicability
The application of this invention is in the field of wound healing, including cervical wounds, as well as in the treatment of anal and prostate cancer in men. Additionally, this innovation can be used for throat and laryngeal cancer and, on the other hand, in burn injuries.
Why is this innovation eligible to receive the IIS certification?
This innovation qualifies for the IFIA Innovation Standard due to its unique and impactful solution for diagnosing and managing HPV-related diseases in men and women, and prevention of cervical cancer in women, and anal and prostate cancer in men, as well as wound healing in other diseases. This invention is about stem cell grafts to repair wounds, especially cervical wounds and the negative side effects of HPV on the cervix. This miraculous graft is effective in other fields of medicine and surgery. It is extracted from the fetal membrane of the place. This invention, through modifications in culture medium formulation, enhancement of the culture environment, and the use of nano-laser technology, represents a significant breakthrough in facilitating treatment worldwide. The manufacturing process has been improved in several ways, including:
- Utilizing advanced technologies and higher-quality materials, which reduce issues related to powdering and adhesion of the dressing.
- Optimized storage methods that, by employing modern preservation techniques, minimize or eliminate the need for refrigeration, reducing storage-related challenges.
- Enhanced production processes and the use of appropriate disinfectants,
Allowing Amniodisc dressings to lower the risk of infection and improve treatment outcomes.
- Easier application to the target area.
- Offering various types of Amniodisc in different sizes and shapes, tailored for thecervix and different types of wounds.
Furthermore, its adaptability across hospitals, clinics, and rehabilitation centers demonstrates its scalability and impact.
